| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 4.23p |
| Change Today | 0.43p |
| % Change | 11.40 % |
| 52 Week High | 4.25 |
| 52 Week Low | 2.10 |
| Volume | 1,444,390 |
| Shares Issued | 533.35m |
| Market Cap | £22.58m |
| Beta | 0.64 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:08 | 52,000 @ 4.20p |
| 15:49 | 25,000 @ 4.15p |
| 15:46 | 55,000 @ 4.19p |
| 15:43 | 311 @ 4.20p |
| 15:43 | 119 @ 4.20p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research